Department of Psychiatry, Kuopio University Hospital & University of Easterrn Finland, 70210 Kuopio, Finland.
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:46-51. doi: 10.1016/j.pnpbp.2013.07.017. Epub 2013 Aug 2.
The majority of depressed individuals report insomnia. Self-reported symptoms of insomnia, in particular, more strongly predict adverse health effects than the actual measured sleep time. The physiological alterations in individuals with insomnia are complex, as both autonomic and endocrine dysfunctions are present. Plasminogen activator inhibitor (PAI)-1 is a stress-related acute-phase reactant that has also been suggested to regulate the circadian rhythm and sleep patterns. It has been suggested to contribute to both depressive symptoms and sleep disorders, although data on the relationships between these parameters are scarce.
This study examined the role of self-reported sleep disturbance and its association with PAI-1 among individuals with a history of depressive symptoms.
Differences in the serum levels of PAI-1 between two groups (group 1: moderate to very severe sleep disturbance, n=37; group 2: mild or no sleep disturbance, n = 90) were examined in a population-based sample of individuals with a recorded history of depressive symptoms.
Multivariate analysis controlling for potential confounding factors (age, sex, body mass index, depression severity) showed that each 1-unit increase in PAI-1 (μg/mL) increased the likelihood for belonging to the group with moderate to very severe sleep disturbance by 23% (OR = 1.23, C.I. 95% = 1.04-1.45, p = 0.016). This statistical significance remained after additional adjustments for regular smoking and the use of sleep or lipid-lowering medication.
Our observations may further clarify the physiological alterations related to sleep disturbance in depressive individuals. In the present study, self-reported sleep disturbance in individuals with a recorded history of depressive symptoms was associated with an elevation of PAI-1. This finding may illustrate the association of subjective sleep disturbance with sympathetic activation. Our study highlights the importance of effects of perceived sleep disturbance on individual homeostasis, and may provide potential directions for research on treatment options.
大多数抑郁患者都有失眠症状。尤其是,与实际测量的睡眠时间相比,自我报告的失眠症状更能预测不良健康影响。失眠患者的生理变化很复杂,因为自主和内分泌功能障碍同时存在。纤溶酶原激活物抑制剂(PAI)-1 是一种与应激相关的急性期反应物,也被认为可以调节昼夜节律和睡眠模式。它被认为与抑郁症状和睡眠障碍都有关系,但关于这些参数之间关系的数据却很少。
本研究旨在探讨有抑郁症状病史的个体中自我报告的睡眠障碍及其与 PAI-1 的关系。
在一个有抑郁症状病史的人群样本中,研究人员比较了两组人群(组 1:中重度至重度睡眠障碍,n=37;组 2:轻度或无睡眠障碍,n=90)之间的血清 PAI-1 水平差异。
在控制了潜在混杂因素(年龄、性别、体重指数、抑郁严重程度)的多变量分析中,PAI-1 每增加 1 个单位(μg/mL),中重度至重度睡眠障碍组的可能性就会增加 23%(OR=1.23,95%置信区间 1.04-1.45,p=0.016)。在进一步调整了规律吸烟和使用睡眠或降脂药物的情况下,这一统计学意义仍然存在。
我们的观察结果可能进一步阐明与抑郁个体睡眠障碍相关的生理变化。在本研究中,有抑郁症状病史的个体的自我报告的睡眠障碍与 PAI-1 升高有关。这一发现可能表明主观睡眠障碍与交感神经激活有关。我们的研究强调了感知到的睡眠障碍对个体内稳态的影响的重要性,并为治疗选择的研究提供了潜在的方向。